ATA151587A - Verfahren zur herstellung einer pharmazeutischen kapsel zur oralen verabreichung mit verzögerter wirkstofffreisetzung bzw. kombinierter verzögerter/rascher wirkstofffreisetzung - Google Patents

Verfahren zur herstellung einer pharmazeutischen kapsel zur oralen verabreichung mit verzögerter wirkstofffreisetzung bzw. kombinierter verzögerter/rascher wirkstofffreisetzung

Info

Publication number
ATA151587A
ATA151587A AT0151587A AT151587A ATA151587A AT A151587 A ATA151587 A AT A151587A AT 0151587 A AT0151587 A AT 0151587A AT 151587 A AT151587 A AT 151587A AT A151587 A ATA151587 A AT A151587A
Authority
AT
Austria
Prior art keywords
active substance
delayed
release
producing
oral administration
Prior art date
Application number
AT0151587A
Other languages
English (en)
Other versions
AT398165B (de
Original Assignee
Norwich Eaton Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norwich Eaton Pharma filed Critical Norwich Eaton Pharma
Publication of ATA151587A publication Critical patent/ATA151587A/de
Application granted granted Critical
Publication of AT398165B publication Critical patent/AT398165B/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
AT0151587A 1986-06-16 1987-06-15 Verfahren zur herstellung einer pharmazeutischen kapsel zur oralen verabreichung mit verzögerter wirkstofffreisetzung bzw. kombinierter verzögerter/rascher wirkstofffreisetzung AT398165B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/874,732 US4798725A (en) 1986-06-16 1986-06-16 Sustained release capsule

Publications (2)

Publication Number Publication Date
ATA151587A true ATA151587A (de) 1994-02-15
AT398165B AT398165B (de) 1994-10-25

Family

ID=25364440

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0151587A AT398165B (de) 1986-06-16 1987-06-15 Verfahren zur herstellung einer pharmazeutischen kapsel zur oralen verabreichung mit verzögerter wirkstofffreisetzung bzw. kombinierter verzögerter/rascher wirkstofffreisetzung

Country Status (13)

Country Link
US (1) US4798725A (de)
EP (1) EP0250038B1 (de)
JP (1) JPH0830007B2 (de)
AT (1) AT398165B (de)
AU (1) AU589866B2 (de)
CA (1) CA1295247C (de)
DE (1) DE3772269D1 (de)
DK (1) DK306587A (de)
IE (1) IE60586B1 (de)
IL (1) IL82806A (de)
NZ (1) NZ220696A (de)
PH (1) PH25179A (de)
ZA (1) ZA874315B (de)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4772473A (en) * 1986-06-16 1988-09-20 Norwich Eaton Pharmaceuticals, Inc. Nitrofurantoin dosage form
NL8701335A (nl) * 1986-06-21 1988-01-18 Sandoz Ag Orale farmaceutische preparaten.
US5071643A (en) * 1986-10-17 1991-12-10 R. P. Scherer Corporation Solvent system enhancing the solubility of pharmaceuticals for encapsulation
US5178880A (en) * 1989-07-25 1993-01-12 Norwich Eaton Pharmaceuticals, Inc. Liquid suspensions of nitrofurantoin
US5332832A (en) * 1989-07-26 1994-07-26 Procter & Gamble Pharmaceuticals, Inc. Nitrofurantoin crystals
JPH03145418A (ja) * 1989-10-27 1991-06-20 Sumitomo Pharmaceut Co Ltd 塩基性薬物塩酸塩の徐放性製剤
US5431916A (en) * 1993-04-29 1995-07-11 The Procter & Gamble Company Pharmaceutical compositions and process of manufacture thereof
US6440457B1 (en) * 1993-05-27 2002-08-27 Alza Corporation Method of administering antidepressant dosage form
US5484607A (en) * 1993-10-13 1996-01-16 Horacek; H. Joseph Extended release clonidine formulation
DE4406424A1 (de) * 1994-02-28 1995-08-31 Bayer Ag Expandierbare Arzneiformen
WO1997017063A1 (en) 1995-11-09 1997-05-15 Microbiological Research Authority Microencapsulated dna for vaccination and gene therapy
US6270795B1 (en) 1995-11-09 2001-08-07 Microbiological Research Authority Method of making microencapsulated DNA for vaccination and gene therapy
IN186245B (de) 1997-09-19 2001-07-14 Ranbaxy Lab Ltd
US8524277B2 (en) * 1998-03-06 2013-09-03 Alza Corporation Extended release dosage form
GB9810236D0 (en) 1998-05-13 1998-07-08 Microbiological Res Authority Improvements relating to encapsulation of bioactive agents
US6406719B1 (en) 1998-05-13 2002-06-18 Microbiological Research Authority Encapsulation of bioactive agents
EP0998932A1 (de) 1998-10-09 2000-05-10 Boehringer Mannheim Gmbh Feste pharmazeutische Darreichungsform enthaltend Diphosphonsäure oder deren Salze und Verfahren zu ihrer Herstellung
CN1195550C (zh) * 1998-12-28 2005-04-06 大正制药株式会社 外用剂
US6383515B2 (en) 1999-05-28 2002-05-07 Sawyer Maryjean Solvent system for enhancing solubility
US6955821B2 (en) * 2000-04-28 2005-10-18 Adams Laboratories, Inc. Sustained release formulations of guaifenesin and additional drug ingredients
US8012504B2 (en) * 2000-04-28 2011-09-06 Reckitt Benckiser Inc. Sustained release of guaifenesin combination drugs
US7985420B2 (en) * 2000-04-28 2011-07-26 Reckitt Benckiser Inc. Sustained release of guaifenesin combination drugs
US7838032B2 (en) * 2000-04-28 2010-11-23 Reckitt Benckiser Inc. Sustained release of guaifenesin
US6372252B1 (en) 2000-04-28 2002-04-16 Adams Laboratories, Inc. Guaifenesin sustained release formulation and tablets
ES2196948B1 (es) * 2001-03-29 2005-02-01 Easyblind, S.L. Persiana enrollable perfeccionada.
US20030012820A1 (en) * 2001-06-12 2003-01-16 Upadhyay Ajay Hasmukhlal Compressible guaifenesin compositions, method for making same and method for making compressed guaifenesin dosage forms therefrom
US20030044458A1 (en) * 2001-08-06 2003-03-06 Curtis Wright Oral dosage form comprising a therapeutic agent and an adverse-effect agent
US6602911B2 (en) * 2001-11-05 2003-08-05 Cypress Bioscience, Inc. Methods of treating fibromyalgia
AU2003225837B2 (en) * 2002-03-15 2008-11-06 Forest Laboratories Holdings Limited NE and 5-HT reuptake inhibitors for treating visceral pain syndromes
US20060003004A1 (en) * 2002-10-25 2006-01-05 Collegium Pharmaceutical, Inc. Pulsatile release compositions of milnacipran
US20040132826A1 (en) * 2002-10-25 2004-07-08 Collegium Pharmaceutical, Inc. Modified release compositions of milnacipran
WO2004058152A2 (en) * 2002-12-16 2004-07-15 Ranbaxy Pharmaceuticals Inc. An extended release pharmaceutical composition of phenytoin sodium
JP2006515008A (ja) * 2003-01-28 2006-05-18 コレギウム ファーマシューティカル， インコーポレイテッド 経口投与のためのミルナシプランの多粒子状組成物
US20050152967A1 (en) * 2003-03-28 2005-07-14 Pfab, Lp Dynamic variable release
US20050202079A1 (en) * 2004-03-15 2005-09-15 Mylan Pharmaceuticals Inc. Novel orally administrable formulation of nitrofurantoin and a method for preparing said formulation
AU2006282506A1 (en) * 2005-08-23 2007-03-01 Nissan Chemical Industries, Ltd. Sustained-release preparation
US7994220B2 (en) * 2005-09-28 2011-08-09 Cypress Bioscience, Inc. Milnacipran for the long-term treatment of fibromyalgia syndrome
JP4926495B2 (ja) * 2006-02-22 2012-05-09 興和株式会社 イブプロフェン含有コーティング顆粒
US7538652B2 (en) * 2006-08-29 2009-05-26 International Business Machines Corporation Electrical component tuned by conductive layer deletion
US20100172991A1 (en) * 2007-06-08 2010-07-08 Henry Joseph Horacek Extended Release Formulation and Methods of Treating Adrenergic Dysregulation
EP2155170A2 (de) * 2007-06-08 2010-02-24 Addrenex Pharmaceuticals, Inc. Formulierung mit verzögerter freisetzung und verfahren zur behandlung adrenerger unregelmässigkeiten
WO2017062997A1 (en) 2015-10-09 2017-04-13 Reckitt Benckiser Llc Pharmaceutical formulation
EP4285895A1 (de) 2022-06-03 2023-12-06 Adalvo Limited Orale dosierungsform von nitrofurantoin

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL171628C (nl) * 1950-05-29 Inst Francais Du Petrole Inrichting voor het uitzenden van akoestische golven in een vloeibaar milieu.
US3401221A (en) * 1964-08-25 1968-09-10 Norwich Pharma Co Treatment of urinary tract infection
US3427378A (en) * 1965-02-12 1969-02-11 American Cyanamid Co Sustained release encapsulated formula
GB1093286A (en) * 1965-02-15 1967-11-29 Biorex Laboratories Ltd Improvements in or relating to dosage unit forms for the administration of medicaments and diagnostic agents
US3458622A (en) * 1967-04-07 1969-07-29 Squibb & Sons Inc Controlled release tablet
GB1204580A (en) * 1968-10-05 1970-09-09 Aspro Nicholas Ltd Pharmaceutical dosage forms
US3634584A (en) * 1969-02-13 1972-01-11 American Home Prod Sustained action dosage form
US3851051A (en) * 1970-07-17 1974-11-26 Scherer R Corp Soft gelatin capsule containing high water content fill
US4152444A (en) * 1972-04-19 1979-05-01 Ciba-Geigy Corporation Pharmaceutical compound preparations with bactericidal action
US4016254A (en) * 1972-05-19 1977-04-05 Beecham Group Limited Pharmaceutical formulations
FR2287216A1 (fr) * 1974-10-09 1976-05-07 Narcisse Guy Nouvelle forme galenique d'administration de medicaments et medicaments prepares sous cette nouvelle forme
US4126672A (en) * 1976-02-04 1978-11-21 Hoffmann-La Roche Inc. Sustained release pharmaceutical capsules
US4122157A (en) * 1977-03-04 1978-10-24 Richardson-Merrell Inc. Nitrofurantoin sustained release tablet
FR2407720A1 (fr) * 1977-11-08 1979-06-01 Lipha Lyonnaise Indle Pharmace Preparations pharmaceutiques orales a activite therapeutique prolongee
US4247552A (en) * 1979-01-11 1981-01-27 Syntex (U.S.A.) Inc. Contraceptive compositions and methods employing 1-substituted imidazole derivatives
CA1146866A (en) * 1979-07-05 1983-05-24 Yamanouchi Pharmaceutical Co. Ltd. Process for the production of sustained release pharmaceutical composition of solid medical material
US4252786A (en) * 1979-11-16 1981-02-24 E. R. Squibb & Sons, Inc. Controlled release tablet
US4370313A (en) * 1981-10-26 1983-01-25 Eaton Laboratories, Inc. Nitrofurantoin dosage form
FR2525108B1 (fr) * 1982-04-19 1989-05-12 Elan Corp Ltd Medicaments a haut degre de solubilite et procede pour leur obtention
JPS61501511A (ja) * 1984-03-21 1986-07-24 アメリカン・ホ−ム・プロダクツ・コ−ポレイション 徐放性医薬カプセル
IE63321B1 (en) * 1986-02-03 1995-04-05 Elan Corp Plc Drug delivery system

Also Published As

Publication number Publication date
JPS63258407A (ja) 1988-10-25
EP0250038B1 (de) 1991-08-21
EP0250038A2 (de) 1987-12-23
EP0250038A3 (en) 1989-01-18
US4798725A (en) 1989-01-17
DE3772269D1 (de) 1991-09-26
CA1295247C (en) 1992-02-04
AU589866B2 (en) 1989-10-19
PH25179A (en) 1991-03-27
ZA874315B (en) 1988-08-31
NZ220696A (en) 1990-08-28
AT398165B (de) 1994-10-25
IE871584L (en) 1987-12-16
IL82806A (en) 1990-11-29
IL82806A0 (en) 1987-12-20
JPH0830007B2 (ja) 1996-03-27
IE60586B1 (en) 1994-07-27
DK306587A (da) 1987-12-17
AU7421287A (en) 1987-12-17
DK306587D0 (da) 1987-06-16

Similar Documents

Publication Publication Date Title
ATA151587A (de) Verfahren zur herstellung einer pharmazeutischen kapsel zur oralen verabreichung mit verzögerter wirkstofffreisetzung bzw. kombinierter verzögerter/rascher wirkstofffreisetzung
ATA151687A (de) Verfahren zur herstellung einer pharmazeutischen kapsel zur oralen verabreichung von nitrofurantoin (-salzen, -hydraten, -komplexen)
DE3485075D1 (de) Pharmazeutische zubereitung zur heilung der erkrankungen der zahnwurzelhaut und verfahren zu deren herstellung.
DE68900994D1 (de) Diphosphonsaeurederivat enthaltendes arzneimittel zur oralen gabe.
DE68915291D1 (de) Verschlusskörpr zur verabreichung einer physiologisch aktiven substanz.
NO871790L (no) Fremgangsmaate for fremstilling av et oralt farmasoeytisk preparat.
DE3888177D1 (de) Schnellauflösbare arzneimitteldosierungseinheit sowie verfahren zur herstellung.
ATE176873T1 (de) Verfahren zur herstellung von applikatoren zur transdermalen verabreichung von medikamenten
FI885101A (fi) Menetelmä lääkettä säännöstellysti vapauttavan annostusmuodon valmistamiseksi
NO173726C (no) Fremgangsmaate for fremstilling av et oralt terapeutisk system for administrering av karbamazpin
DE3886965D1 (de) Zubereitungen zur gesteuerten Wirkstofffreisetzung.
NO885641D0 (no) Fremgangsmaate for fremstilling av farmasoeytisk preparat.
NO178564C (no) Framgangsmåte for framstilling av et system for administrering av aktive medikamenter gjennom slimhinner
AT385199B (de) Verfahren zur herstellung eines pharmazeutischen praeparates mit verzoegerter wirkstofffreigabe
AT381639B (de) Verfahren zur herstellung pharmazeutischer tabletten mit verzoegerter wirkstofffreigabe
ATA164187A (de) Verfahren zur herstellung eines pharmazeutischen pulvers
ATA156187A (de) Verfahren zur herstellung einer festen oralen pharmazeutischen ketotifenzusammensetzung
DE3883206D1 (de) Arzneistoff enthaltende fettemulsion des typs "kurz vor gebrauch hergestellt" sowie verfahren zur herstellung einer arzneihaltigen fettemulsion.
ATA245988A (de) Verfahren zur herstellung einer analgetischen und antiinflammatorischen pharmazeutischen zubereitung
DE69103922D1 (de) Verfahren zur Herstellung arzneistoffhaltiger Tabletten mit verzögerter Freigabe.
NO870104D0 (no) Farmasoeytisk preparat med vedvarende frigivelse av den aktive komponenten og fremgangsmaate for fremstilling derav.
ATA18588A (de) Verfahren zur herstellung eines pharmazeutischen trockenpräparates enthaltend ein diclofenac-salz
AT386950B (de) Verfahren zur herstellung einer stabilen waessrigen fettemulsion zur intravenoesen verabreichung
ATA81985A (de) Verfahren zur herstellung einer zur oralen verabreichung von etoposid bestimmten weichgelantinekapsel
DE3761767D1 (de) Verfahren zur herstellung optisch aktiver 2-hydroxyethyl-azol- derivate.

Legal Events

Date Code Title Description
EFA Change in the company name
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties
ELA Expired due to lapse of time